Europe Squalene Market Report: Market Size & Forecast 2026

The European squalene market encompasses the production, distribution, and consumption of squalene across three primary sourcing categories: animal-derived, plant-derived, and synthetic. In 2025, the market holds a value of roughly $60 million, with projections indicating robust expansion over the coming decade. Squalene's chemical versatility makes it a valuable ingredient across pharmaceutical formulations, cosmetic products, and dietary supplement applications.

• •Market valued at approximately $60 million in 2025 with a 10.6% projected annual growth rate
• •Three primary sourcing segments: animal-based (traditional shark liver oil), plant-based (olive, amaranth, sugarcane), and synthetic
• •Key end-use categories include pharmaceuticals, personal care and cosmetics, and nutraceuticals

A primary catalyst for market expansion is the surging demand within the cosmetics and personal care industry, where squalene is widely incorporated into skincare products for its moisturizing, emollient, and skin-compatible properties. Rising consumer preference for clean beauty and sustainable sourcing has accelerated the shift from animal-based to plant-derived and biosynthetic squalene. Additionally, pharmaceutical applications, particularly squalene-based adjuvants used in vaccines and immunology treatments, provide a stable demand pillar.

• •Rising demand for squalene in anti-aging and moisturizing cosmetic formulations across European markets
• •Shift toward plant-based and synthetic squalene driven by sustainability concerns and regulatory pressure on shark-derived products
• •Pharmaceutical demand supported by squalene's role as a vaccine adjuvant and drug delivery component

The European market is typically segmented by source type, application category, and individual country markets. Western European nations, including France, Germany, the United Kingdom, and Italy, represent the largest consumption hubs, supported by a dense concentration of personal care manufacturers and pharmaceutical companies. Plant-based squalene has been gaining share rapidly as olive-derived squalene production expands in Mediterranean regions such as Spain and Italy, which are naturally suited to olive cultivation.

• •Western Europe dominates regional consumption, led by France, Germany, the UK, and Italy
• •Plant-based source segment is outpacing animal-based sourcing amid sustainability and vegan-product trends
• •Pharmaceuticals and personal care/cosmetics together account for the majority of end-use demand

What are the recent trends and outlook?

The market is expected to sustain double-digit growth through 2032, fueled by continued expansion in the cosmetics sector, rising pharmaceutical demand, and increasing regulatory and consumer pressure to move away from animal-derived ingredients. Innovation in synthetic biology and fermentation-based production methods is anticipated to bring down costs and improve scalability. Companies investing in sustainable sourcing, transparent supply chains, and high-purity extraction technologies are well-positioned to capture the growing market opportunity across Europe.

• •Long-term growth projected through 2032-2033, with plant-based and synthetic squalene gaining significant market share
• •Advances in synthetic biology and fermentation technology expected to improve cost competitiveness of non-animal squalene
• •Regulatory pressure and consumer demand for cruelty-free and vegan-certified products driving sourcing transitions